$317 Million is the total value of Iguana Healthcare Management, LLC's 69 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 104.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | SPDR S&P 500 ETF TRput | $20,585,000 | – | 100,000 | +100.0% | 6.49% | – | |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $20,478,000 | +88.5% | 200,000 | +14.3% | 6.46% | +41.3% |
| CELG | Buy | CELGENE CORP | $17,360,000 | +36.9% | 150,000 | +36.4% | 5.48% | +2.7% |
| New | SELECT SECTOR SPDR TRput | $14,878,000 | – | 200,000 | +100.0% | 4.69% | – | |
| New | PFIZER INCcall | $13,412,000 | – | 400,000 | +100.0% | 4.23% | – | |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $12,264,000 | -33.8% | 150,000 | -25.0% | 3.87% | -50.3% |
| GILD | GILEAD SCIENCES INC | $11,708,000 | +19.3% | 100,000 | 0.0% | 3.69% | -10.5% | |
| AMGN | New | AMGEN INC | $9,211,000 | – | 60,000 | +100.0% | 2.91% | – |
| ESRX | Buy | EXPRESS SCRIPTS HLDG CO | $8,894,000 | +70.8% | 100,000 | +66.7% | 2.81% | +28.1% |
| ANTM | Buy | ANTHEM INC | $8,207,000 | +165.8% | 50,000 | +150.0% | 2.59% | +99.3% |
| VRX | New | VALEANT PHARMACEUTICALS INTL | $7,775,000 | – | 35,000 | +100.0% | 2.45% | – |
| MDT | New | MEDTRONIC PLC | $7,410,000 | – | 100,000 | +100.0% | 2.34% | – |
| STJ | Buy | ST JUDE MED INC | $7,307,000 | +49.0% | 100,000 | +33.3% | 2.30% | +11.7% |
| AXDX | Buy | ACCELERATE DIAGNOSTICS INC | $6,969,000 | +23.9% | 270,000 | +8.0% | 2.20% | -7.1% |
| HZNP | HORIZON PHARMA PLC | $6,948,000 | +33.8% | 200,000 | 0.0% | 2.19% | +0.3% | |
| PFE | Sell | PFIZER INC | $6,706,000 | -67.9% | 200,000 | -66.7% | 2.12% | -75.9% |
| CI | Buy | CIGNA CORPORATION | $6,480,000 | +66.9% | 40,000 | +33.3% | 2.04% | +25.2% |
| New | AETNA INC NEWcall | $6,373,000 | – | 50,000 | +100.0% | 2.01% | – | |
| BIIB | New | BIOGEN INC | $6,059,000 | – | 15,000 | +100.0% | 1.91% | – |
| IPXL | Buy | IMPAX LABORATORIES INC | $5,740,000 | +63.3% | 125,000 | +66.7% | 1.81% | +22.4% |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $5,528,000 | +21.3% | 45,000 | -10.0% | 1.74% | -9.0% |
| MYL | New | MYLAN N V | $5,090,000 | – | 75,000 | +100.0% | 1.61% | – |
| EW | New | EDWARDS LIFESCIENCES CORP | $4,985,000 | – | 35,000 | +100.0% | 1.57% | – |
| New | ABBOTT LABScall | $4,908,000 | – | 100,000 | +100.0% | 1.55% | – | |
| NVDQ | Buy | NOVADAQ TECHNOLOGIES INC | $4,844,000 | +49.1% | 400,000 | +100.0% | 1.53% | +11.9% |
| XLRN | Sell | ACCELERON PHARMA INC | $4,746,000 | -28.7% | 150,000 | -14.3% | 1.50% | -46.6% |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $4,500,000 | -25.6% | 265,000 | -47.0% | 1.42% | -44.2% |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDadr | $4,433,000 | – | 75,000 | +100.0% | 1.40% | – |
| IPCM | Buy | IPC HEALTHCARE INC | $4,154,000 | +154.5% | 75,000 | +114.3% | 1.31% | +90.7% |
| TRNX | TORNIER N V | $3,749,000 | -4.7% | 150,000 | 0.0% | 1.18% | -28.5% | |
| MDRX | New | ALLSCRIPTS HEALTHCARE SOLUTN | $3,420,000 | – | 250,000 | +100.0% | 1.08% | – |
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $3,371,000 | +69.7% | 175,000 | +16.7% | 1.06% | +27.3% |
| IMDZ | Buy | IMMUNE DESIGN CORP | $3,098,000 | +46.8% | 150,000 | +50.0% | 0.98% | +10.0% |
| ELGX | Buy | ENDOLOGIX INC | $3,068,000 | +259.3% | 200,000 | +300.0% | 0.97% | +169.6% |
| PETX | ARATANA THERAPEUTICS INC | $3,024,000 | -5.6% | 200,000 | 0.0% | 0.95% | -29.2% | |
| ISIS | New | ISIS PHARMACEUTICALS INC | $2,878,000 | – | 50,000 | +100.0% | 0.91% | – |
| New | AGIOS PHARMACEUTICALS INCput | $2,779,000 | – | 25,000 | +100.0% | 0.88% | – | |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $2,680,000 | +155.0% | 90,000 | +100.0% | 0.84% | +91.2% |
| T107PS | WRIGHT MED GROUP INC | $2,626,000 | +1.8% | 100,000 | 0.0% | 0.83% | -23.7% | |
| New | HEALTH NET INCcall | $2,565,000 | – | 40,000 | +100.0% | 0.81% | – | |
| TTPH | Sell | TETRAPHASE PHARMACEUTICALS I | $2,372,000 | -13.7% | 50,000 | -33.3% | 0.75% | -35.3% |
| NUVA | New | NUVASIVE INC | $2,369,000 | – | 50,000 | +100.0% | 0.75% | – |
| AGTC | New | APPLIED GENETIC TECHNOL CORP | $2,301,000 | – | 150,000 | +100.0% | 0.73% | – |
| RXDX | New | IGNYTA INC | $2,264,000 | – | 150,000 | +100.0% | 0.71% | – |
| OMED | New | ONCOMED PHARMACEUTICALS INC | $2,250,000 | – | 100,000 | +100.0% | 0.71% | – |
| ENDP | Sell | ENDO INTL PLC | $1,991,000 | -63.0% | 25,000 | -58.3% | 0.63% | -72.3% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $1,892,000 | -32.1% | 75,000 | -25.0% | 0.60% | -49.1% |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $1,584,000 | +80.8% | 275,000 | +83.3% | 0.50% | +35.9% |
| EPZM | New | EPIZYME INC | $1,560,000 | – | 65,000 | +100.0% | 0.49% | – |
| KITE | New | KITE PHARMA INC | $1,524,000 | – | 25,000 | +100.0% | 0.48% | – |
| DERM | DERMIRA INC | $1,404,000 | +14.3% | 80,000 | 0.0% | 0.44% | -14.3% | |
| AFMD | New | AFFIMED N V | $1,347,000 | – | 100,000 | +100.0% | 0.42% | – |
| CNAT | New | CONATUS PHARMACEUTICALS INC | $1,288,000 | – | 250,000 | +100.0% | 0.41% | – |
| New | ESPERION THERAPEUTICS INC NEcall | $1,226,000 | – | 15,000 | +100.0% | 0.39% | – | |
| SCYX | New | SCYNEXIS INC | $1,099,000 | – | 125,000 | +100.0% | 0.35% | – |
| New | SPARK THERAPEUTICS INCcall | $1,055,000 | – | 17,500 | +100.0% | 0.33% | – | |
| DRNA | New | DICERNA PHARMACEUTICALS INC | $1,046,000 | – | 75,000 | +100.0% | 0.33% | – |
| GENN | New | GENESIS HEALTHCARE INC | $990,000 | – | 150,000 | +100.0% | 0.31% | – |
| CSLT | Sell | CASTLIGHT HEALTH INCcl b | $977,000 | -37.0% | 120,000 | -40.0% | 0.31% | -52.8% |
| New | SPARK THERAPEUTICS INCput | $904,000 | – | 15,000 | +100.0% | 0.28% | – | |
| ETRM | Sell | ENTEROMEDICS INC | $667,000 | -49.5% | 1,075,000 | -25.6% | 0.21% | -62.2% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $646,000 | -81.3% | 240,000 | -52.0% | 0.20% | -86.0% |
| New | NOVADAQ TECHNOLOGIES INCcall | $606,000 | – | 50,000 | +100.0% | 0.19% | – | |
| HWAY | New | HEALTHWAYS INC | $599,000 | – | 50,000 | +100.0% | 0.19% | – |
| New | FLAMEL TECHNOLOGIES SAcall | $530,000 | – | 25,000 | +100.0% | 0.17% | – | |
| MEIP | Buy | MEI PHARMA INC | $428,000 | +59.1% | 250,000 | +66.7% | 0.14% | +19.5% |
| New | IMMUNOMEDICS INCcall | $305,000 | – | 75,000 | +100.0% | 0.10% | – | |
| New | ZIOPHARM ONCOLOGY INCput | $300,000 | – | 25,000 | +100.0% | 0.10% | – | |
| New | MEI PHARMA INCcall | $257,000 | – | 150,000 | +100.0% | 0.08% | – | |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -50,000 | -100.0% | -0.08% | – |
| TLOG | Exit | TETRALOGIC PHARMACEUTICALS C | $0 | – | -100,000 | -100.0% | -0.18% | – |
| DEPO | Exit | DEPOMED INC | $0 | – | -25,000 | -100.0% | -0.24% | – |
| TSRO | Exit | TESARO INC | $0 | – | -10,000 | -100.0% | -0.24% | – |
| OSUR | Exit | ORASURE TECHNOLOGIES INC | $0 | – | -105,000 | -100.0% | -0.29% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -100,000 | -100.0% | -0.46% | – |
| HAE | Exit | HAEMONETICS CORP | $0 | – | -25,000 | -100.0% | -0.47% | – |
| FLXN | Exit | FLEXION THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.47% | – |
| KND | Exit | KINDRED HEALTHCARE INC | $0 | – | -50,000 | -100.0% | -0.50% | – |
| TXMD | Exit | THERAPEUTICSMD INC | $0 | – | -200,000 | -100.0% | -0.51% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -25,000 | -100.0% | -0.64% | – |
| SPNC | Exit | SPECTRANETICS CORP | $0 | – | -50,000 | -100.0% | -0.73% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -50,000 | -100.0% | -0.84% | – |
| HCP | Exit | HCP INC | $0 | – | -50,000 | -100.0% | -0.91% | – |
| FLML | Exit | FLAMEL TECHNOLOGIES SAsponsored adr | $0 | – | -125,000 | -100.0% | -0.95% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -50,000 | -100.0% | -0.98% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -50,000 | -100.0% | -0.98% | – |
| DYAX | Exit | DYAX CORP | $0 | – | -150,000 | -100.0% | -1.06% | – |
| LGND | Exit | LIGAND PHARMACEUTICALS INC | $0 | – | -35,000 | -100.0% | -1.14% | – |
| MRK | Exit | MERCK & CO INC NEW | $0 | – | -50,000 | -100.0% | -1.21% | – |
| MDVN | Exit | MEDIVATION INC | $0 | – | -25,000 | -100.0% | -1.36% | – |
| CAH | Exit | CARDINAL HEALTH INC | $0 | – | -40,000 | -100.0% | -1.52% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -120,000 | -100.0% | -1.58% | – |
| WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -45,000 | -100.0% | -1.73% | – |
| HUM | Exit | HUMANA INC | $0 | – | -30,000 | -100.0% | -2.25% | – |
| ZBH | Exit | ZIMMER HLDGS INC | $0 | – | -50,000 | -100.0% | -2.47% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -25,000 | -100.0% | -2.48% | – |
| IWM | Exit | ISHARES TRrussell 2000 etf | $0 | – | -50,000 | -100.0% | -2.62% | – |
| B108PS | Exit | ACTAVIS PLC | $0 | – | -25,000 | -100.0% | -3.13% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 17 | Q1 2018 | 7.5% |
| ULTRAGENYX PHARMACEUTICAL IN | 17 | Q1 2018 | 6.7% |
| MERCK & CO INC NEW | 16 | Q1 2018 | 5.4% |
| CELGENE CORP | 15 | Q4 2017 | 7.9% |
| AERIE PHARMACEUTICALS INC | 15 | Q4 2017 | 3.3% |
| GILEAD SCIENCES INC | 14 | Q1 2017 | 6.7% |
| ESPERION THERAPEUTICS INC NE | 14 | Q1 2018 | 7.8% |
| SUPERNUS PHARMACEUTICALS INC | 14 | Q4 2017 | 2.8% |
| DERMIRA INC | 14 | Q1 2018 | 2.7% |
| AMGEN INC | 13 | Q1 2017 | 6.5% |
View Iguana Healthcare Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-16 |
| 13F-HR | 2017-11-14 |
| 13F-HR | 2017-08-14 |
| 13F-HR | 2017-05-15 |
| 13F-HR | 2017-02-14 |
| 13F-HR/A | 2016-11-17 |
| 13F-HR | 2016-11-14 |
| 13F-HR/A | 2016-11-04 |
View Iguana Healthcare Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.